Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition.
International Journal Of Oncology
Ioannou, Nikolaos N; Seddon, Alan M AM; Dalgleish, Angus A; Mackintosh, David D; Solca, Flavio F; Modjtahedi, Helmout H